Week in review: Bevacizumab biosimilar, eyelash entrapment, DME drug
- Posted on: Jul 5 2019
- Leave a response
This week, a bevacizumab biosimilar wins FDA approval, doctors remove an entrapped eyelash from a conjunctival ulcer and Oxurion’s plasma kallikrein inhibitor resolves diabetic macular edema in a phase 1 study.
Source: AAO
Posted in: Uncategorized
